Advertisement
Research Article

OX40 Facilitates Control of a Persistent Virus Infection

  • Tobias Boettler equal contributor,

    equal contributor Contributed equally to this work with: Tobias Boettler, Friedrich Moeckel

    Affiliation: Division of Developmental Immunology, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America

    X
  • Friedrich Moeckel equal contributor,

    equal contributor Contributed equally to this work with: Tobias Boettler, Friedrich Moeckel

    Affiliation: Division of Developmental Immunology, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America

    X
  • Yang Cheng,

    Affiliation: Division of Developmental Immunology, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America

    Current address: University College London, Division of Infection and Immunity, London, Great Britain.

    X
  • Maximilian Heeg,

    Affiliation: Division of Developmental Immunology, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America

    Current address: University Hospital Freiburg, Department of Gastroenterology and Hepatology, Freiburg, Germany.

    X
  • Shahram Salek-Ardakani,

    Affiliation: Division of Immune Regulation, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America

    X
  • Shane Crotty,

    Affiliation: Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America

    X
  • Michael Croft,

    Affiliation: Division of Immune Regulation, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America

    X
  • Matthias G. von Herrath mail

    matthias@liai.org

    Affiliation: Division of Developmental Immunology, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America

    X
  • Published: September 06, 2012
  • DOI: 10.1371/journal.ppat.1002913

About the Authors

Tobias Boettler, Friedrich Moeckel, Yang Cheng, Maximilian Heeg, Matthias G. von Herrath
Division of Developmental Immunology, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America
Shahram Salek-Ardakani, Michael Croft
Division of Immune Regulation, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America
Shane Crotty
Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America

Corresponding Author

Email: matthias@liai.org

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

Conceived and designed the experiments: TB FM SSA SC MC MvH. Performed the experiments: TB FM YC MH. Analyzed the data: TB FM. Contributed reagents/materials/analysis tools: SSA SC MC. Wrote the paper: TB FM MC SC MvH.